Healthcare
Aescap Venture et al in £4.2m round for Aquapharm
Aescap Venture, Tate & Lyle Ventures, Highlands and Islands Enterprise and NESTA have participated in a £4.2m series-C round for UK marine biotech firm Aquapharm Biodiscovery.
Private equity consortium looks to take Sorin private
A consortium comprised of Ares Life Sciences AG, Essex Woodlands Health Ventures UK, Intesa SanPaolo and Alpha Private Equity Funds has requested permission to carry out an exclusive due diligence process on healthcare business Sorin Group.
Sunstone Capital backs merger of IMIX and Arcoma
Danish venture capital firm Sunstone Capital has invested and undisclosed sum in IMIX, a provider of superior digital radiography.
Intesa and Innogest in €5m round for Silicon Biosystems
Atlante Ventures, the Venture Capital Fund of the Intesa Sanpaolo Group, and Innogest Capital have co-led a €5m round of financing for Silicon Biosystems SpA.
Apposite backs SureCalm MBI
Healthcare-focused investor Apposite Capital has backed the management buy-in of healthcare services provider, SureCalm Healthcare. No financial details have been disclosed.
Valedo makes four add-ons to Swedish psychiatry group
Valedo Partners has completed four add-on acquisitions for its portfolio company Specialistpsykiatrigruppen.
Forbion opens Munich office; appoints partner
Dutch venture firm Forbion Capital Partners has opened a new office in Munich and appointed Dr Holger Reithinger as partner.
Siemens aborts plans to sell hearing aids unit
According to reports, the sale of Siemens Audiologische Technik, the hearing aids business of Siemens AG has now definitely been cancelled.
MIG Fonds et al. in €13m Antisense round
MIG Fonds and Global Asset Management have invested a further €13m in biotechnology company Antisense Pharma GmbH, with management and private investors also taking part in the financing.
Cinven to buy Sebia from Montagu
Cinven is set to buy French medical diagnostic company, Sebia, from Montagu Private Equity in a secondary buyout deal reportedly valued at €800m.
AGF leads €13.1m round for Genticel
AGF Private Equity has led a €13.1m round for biotech business Genticel alongside three new investors: Institut Régional de Développement Industriel (IRDI), Amundi Private Equity Funds and CDC Entreprises’ InnoBio fund.
Advent appoints operating partner for health sector
Advent International has appointed Christian Grenier as operating partner. He will provide advice on investment opportunities in the healthcare and specialty chemical sectors.
FVW and Clusterfonds Innovation invest in SurgicEye
FVW Investments For Your Health Beteiligungs GmbH and Bayern Kapital have provided a seven digit series-A financing round for medical technology company SurgicEye GmbH.
BPE acquires Domilens
BPE Unternehmensbeteiligungen GmbH has, together with the management team, wholly acquired medical supplies company Domilens GmbH from STAAR Surgical AG, Switzerland.
OFI-backed IMV Technologies acquires NIFA
OFI Private Equity Capital-backed biotech firm IMV Technologies has wholly acquired has wholly acquired sector player NIFA’s shares from its founding shareholders.
3i and N.I. Partners acquire Apax's stake in Vedici
3i and N.I. Partners have acquired a stake in acute care company Vedici, alongside founding directors Jérôme Nouzarède and Michel Bodkier, from Apax Partners SA and its listed vehicle Altamir Amboise.
HgCapital investigates understated profits by Goldshield
HgCapital has already appointed auditors and lawyers to investigate the alleged understatement of profits by portfolio company Goldshield Group, the drug business the investor took private in a £179m deal last year.
Braveheart leads further £500,000 financing for Tayside
Technology-focused investor Braveheart has led a further funding round for life science business Tayside Flow Technologies worth more than £500,000.
Bridgepoint to acquire Care UK in £280m deal
Bridgepoint has agreed to acquire listed health and social care company Care UK for 450 pence per share, in a deal that values the business at £281m.
Venture back in the spotlight
Venture capital in the UK is booming this week following two major deals in the healthcare sector. Deborah Sterescu reports.
Novo and Warburg invest £65m in Archimedes Pharma
New investor Novo Growth Equity has led a £65m fundraise for specialty pharmaceutical company Archimedes Pharma alongside existing backer Warburg Pincus.
Encore Ventures and MTI exit ApaTech in $330m deal
Encore Ventures and MTI Partners have exited their investment in orthobiologics products company ApaTech via a trade sale to healthcare business Baxter Inc. for a total consideration of up to $330m.
Banks seize control of 3i-backed Ultralase
Senior lenders have reportedly taken control of 3i-backed Ultralase, the UK laser eye surgery chain, as part of a pre-pack administration, making it the second of the private equity firm's portfolio companies to fall within a week.
gamma capital partners in partial exit of Siesta Group
gamma capital partners has sold part of medical services company Siesta Group to Royal Philips Electronic.